Fund Holdings — First Turn Management, LLC

Total Portfolio Value:
$875.20M
Total Bought:
$372.92M
Total Sold:
$222.75M
Net Transaction:
+$150.17M
Notable People:
Lisa Gable Wheatley, Tracy Austin Murphy, Stephen Allyn Rosetta
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ABIVAX Société AnonymeADS(ABVX)291,820381,233+89,413$24.78M$51.41M5.87%+$26.64M
Revolution Medicines, Inc.(RVMD)643,050638,385-4,665$30.03M$50.85M5.81%+$20.82M
Insmed Incorporated(INSM)319,773264,293-55,480$46.05M$46.00M5.26%-$53.0K
BridgeBio Pharma, Inc.(BBIO)589,729595,473+5,744$30.63M$45.55M5.20%+$14.92M
Mirum Pharmaceuticals, Inc.(MIRM)570,569481,564-89,005$41.83M$38.04M4.35%-$3.79M
Axsome Therapeutics, Inc.(AXSM)152,614206,921+54,307$18.53M$37.79M4.32%+$19.26M
Nuvalent Inc394,754368,697-26,057$34.14M$37.09M4.24%+$2.95M
Xenon Pharmaceuticals Inc.(XENE)799,743799,7430$32.11M$35.84M4.10%+$3.73M
Apogee Therapeutics Inc402,811474,839+72,028$16.00M$35.84M4.10%+$19.84M
Terns Pharmaceuticals Inc0872,049+872,049$0$35.23M4.03%+$35.23M
Newamsterdam Pharma Company
ORDINARY SHARES
716,971893,473+176,502$20.39M$31.34M3.58%+$10.95M
United Therapeutics Corporation(UTHR)85,31863,580-21,738$35.77M$30.98M3.54%-$4.79M
Vera Therapeutics, Inc.CL A(VERA)354,529601,774+247,245$10.30M$30.47M3.48%+$20.17M
Cogent Biosciences, Inc.(COGT)0824,283+824,283$0$29.28M3.35%+$29.28M
Ascendis Pharma A/SADR(ASND)146,291131,808-14,483$29.08M$28.11M3.21%-$977.4K
Guardant Health, Inc.(GH)0271,685+271,685$0$27.75M3.17%+$27.75M
Roivant Sciences Ltd.SHS(ROIV)959,7031,186,817+227,114$14.52M$25.75M2.94%+$11.23M
IDEAYA Biosciences, Inc.(IDYA)0723,653+723,653$0$25.02M2.86%+$25.02M
Viridian Therapeutics, Inc.(VRDN)0690,528+690,528$0$21.49M2.46%+$21.49M
Fulcrum Therapeutics, Inc.(FULC)01,892,683+1,892,683$0$21.41M2.45%+$21.41M
Cytokinetics, Incorporated(CYTK)254,795325,668+70,873$14.00M$20.69M2.36%+$6.69M
Scholar Rock Holding Corporation(SRRK)0459,727+459,727$0$20.25M2.31%+$20.25M
argenx SEADR(ARGX)38,76723,256-15,511$28.59M$19.56M2.23%-$9.04M
Natera, Inc.(NTRA)80,87580,8750$13.02M$18.53M2.12%+$5.51M
ORIC Pharmaceuticals, Inc.(ORIC)2,159,4742,010,307-149,167$25.91M$16.44M1.88%-$9.47M
Kymera Therapeutics, Inc.(KYMR)277,726206,445-71,281$15.72M$16.06M1.84%+$344.2K
Rhythm Pharmaceuticals, Inc.(RYTM)0146,303+146,303$0$15.66M1.79%+$15.66M
Olema Pharmaceuticals, Inc.(OLMA)0617,714+617,714$0$15.44M1.76%+$15.44M
Arcus Biosciences, Inc.(RCUS)0565,142+565,142$0$13.47M1.54%+$13.47M
Disc Medicine, Inc.(IRON)397,693153,206-244,487$26.28M$12.17M1.39%-$14.11M
Praxis Precision Medicines, Inc.(PRAX)035,749+35,749$0$10.54M1.20%+$10.54M
uniQure N.V.SHS(QURE)0321,655+321,655$0$7.70M0.88%+$7.70M
MoonLake ImmunotherapeuticsCL A(MLTX)262,643262,6430$1.88M$3.46M0.40%+$1.58M
Adma Biologics Inc808,6730-808,673$11.86M$0—-$11.86M
Akero Therapeutics Inc397,0100-397,010$18.85M$0—-$18.85M
Arcellx Inc
COMMON STOCK
313,7330-313,733$25.76M$0—-$25.76M
Enliven Therapeutics Inc783,4110-783,411$16.04M$0—-$16.04M
Harrow, Inc.(HROW)160,2340-160,234$7.72M$0—-$7.72M
Janux Therapeutics, Inc.(JANX)639,6990-639,699$15.63M$0—-$15.63M
Merus N V372,0220-372,022$35.03M$0—-$35.03M
Neurocrine Biosciences, Inc.(NBIX)181,8970-181,897$25.53M$0—-$25.53M
Page 1 of 1
First Turn Management, LLC — 13F Holdings — Q4 2025 | TickerTrail